Upload Avatar (500 x 500)
Wang Bo
rmh_wb@whu.edu.cn
Chinese, English
Hubei
Wuhan University
Medical School
  • 2006.09-2011.06 Bachelor of Medicine: Guangdong Medical University
  • 2011.09-2016.06 PhD in Surgery: Tongji Medical College, Huazhong University of Science and Technology
  • Published over 10 SCI papers with the highest impact factor of 12.17
  • 2016.07-2019.11 Attending Physician, Department of Thoracic Surgery, Renmin Hospital of Wuhan University
  • 2019.11-present Associate Chief Physician, Associate Professor, Master's Supervisor, Department of Thoracic Surgery, Renmin Hospital of Wuhan University
  • 2023 Medical Elite of Renmin Hospital of Wuhan University
  • 2022 Medical Spring Seedling of Renmin Hospital of Wuhan University
  • 2021 Advanced Individual in Medical Ethics and Style of Renmin Hospital of Wuhan University
  • 2020 May Fourth Youth Medal of Renmin Hospital of Wuhan University
  • 2020 Active Member of the Trade Union of Renmin Hospital of Wuhan University
  • 2018 Advanced Worker of Renmin Hospital of Wuhan University
  • 2020 Anti-Epidemic Pioneer of Wuchang Fangcang Hospital
  • 2020 First Prize of Hubei Province Science and Technology Progress Award for 'Mechanism and Clinical Key Technology Innovation of Lung Transplant Ischemia Reperfusion Injury'
  • 2017 Second Prize of Hubei Province Science and Technology Progress Promotion Award for 'Innovation and Clinical Promotion Application of Colon Esophagus Surgery Technology'
Pathogenesis and clinical prevention of lung injury caused by sepsis and ischemia reperfusion
  • Targeting immunometabolism against acute lung injury, Ning, L., Shishi, Z., Bo, W., & Huiqing, L., 2023
  • HDAC3 deficiency protects against acute lung injury by maintaining epithelial barrier integrity through preserving mitochondrial quality control, Li, N., Liu, B., Xiong, R., Li, G., Wang, B., & Geng, Q., 2023
  • Oral Hydroxychloroquine Mitigates Lipopolysaccharide-induced Lung Injury by Inhibiting Pyroptosis in Mice, Xiong, R., Li, N., Xiong, J., Liu, B., He, R., Wang, B., & Geng, Q., 2023
  • PM2.5 contributed to pulmonary epithelial senescence and ferroptosis by regulating USP3-SIRT3-P53 axis, Li, N., Xiong, R., Li, G., Wang, B., & Geng, Q., 2023
  • Mangiferin Mitigates Lipopolysaccharide-Induced Lung Injury by Inhibiting NLRP3 Inflammasome Activation, Li, N., Xiong, R., He, R., Liu, B., Wang, B., & Geng, Q., 2021
  • PM2.5-induced lung injury is attenuated in macrophage-specific NLRP3 deficient mice, Xiong, R., Jiang, W., Li, N., Liu, B., He, R., Wang, B., & Geng, Q., 2021
  • Plasma extracellular vesicle delivery of miR-210-3p by targeting ATG7 to promote sepsis-induced acute lung injury by regulating autophagy and activating inflammation, Li, G., Wang, B., Ding, X., Zhang, X., Tang, J., & Lin, H., 2021
  • RAGE deficiency alleviates aortic valve calcification in ApoE-/- mice via the inhibition of endoplasmic reticulum stress, Wang, B., Cai, Z., Liu, B., Liu, Z., Zhou, X., Dong, N., & Li, F., 2017
  • Reconstruction of the esophagus of patients with middle thoracic esophageal carcinoma using the remnant stomach following Billroth II gastrectomy, Mao, Z., Wang, B., Dong, P., Liu, G., Hu, H., Zhang, S., Pan, S., & Huang, J., 2021
  • Double lung transplantation for end-stage Kartagener syndrome: a case report and literature review, Wang, B., Zhang, X., Jiang, W., Huang, J., Chen, J., Kreisel, D., Danguilan, J. L. J., Hsin, M., & Lin, H., 2020
  • First lung transplant in Wuhan for a critical and elderly COVID-19 patient, Wang, B., Huang, J., Hsin, M., Chen, J., & Lin, H., 2021
  • Aβ40 Promotes the Osteoblastic Differentiation of Aortic Valve Interstitial Cells through the RAGE Pathway, Wang, B., Lin, H. Q., Li, F., Mao, Z. F., & Dong, N. G., 2020
  • The critical roles of histone deacetylase 3 in the pathogenesis of solid organ injury, Ning, L., Rui, X., Bo, W., & Qing, G., 2021
Sepsis Lung Injury Ischemia Reperfusion Pathogenesis Clinical Prevention Acute Lung Injury Research Treatment Mechanism

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.